Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
targeted cancer drugs
MedTech
ASCO: Illumina cancer exec on 'democratizing genomic profiling'
“Our data show that an enormous and even alarming number of patients are not getting genomic profiling,” said Kevin Keegan, Illumina's oncology head.
Andrea Park
Jun 3, 2023 7:28pm
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Oct 13, 2021 8:40am
New cancer targets unveiled in map of protein interactions
Oct 1, 2021 9:00am
CRISPR pinpoints new AML target and its 'druggable pocket'
Aug 23, 2021 9:25am
Tyra Biosciences wants to bank $100M for an IPO
Aug 23, 2021 7:05am
Novel degrader of cancer-driving protein slows tumors in mice
Jul 23, 2021 10:00am
